chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

RGC
Regencell Bioscience Holdings Limited
stockNASDAQ

Market OpenOct 15, 2026 2:21:53 PM EDT
10.80USD+33.169%(+2.69)1,552,915
Pre-marketOct 15, 2026 9:25:30 AM EDT
7.98USD-1.603%(-0.13)
9.3000Bid10.62Ask1.3200Spread
Loading…
Loading…
Market Cap
5.35B
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
HQ
Causeway Bay, TN, Hong Kong
Employees
26,000
Previous Close
$8.11
Beta
1.37
52-Week High
$69.00 2026-01-08
52-Week Low
$4.51 2026-07-17
SMA 50
$6.07
SMA 200
$18.63
Avg. Vol 10D
292,981
Avg. Vol 30D
214,649
Avg. Vol 90D
279,867
Relative Vol
7.22
Shares Out
495.88M
Float
17.28M
Free Float %
3.49%
Short Interest
656,182
Short Interest %
3.80%
Days to Cover
7.29
On/Off Exchange
52%/48%
Short Vol %
62.93%
Short Vol % (off-exch)
39.61%
Borrow Fee
167.3100%
Borrow Avail.
150,000
FTDs
6,169
FTDs 30d avg
10,660
FTDs 30d high
35,922
Last Split
Jun 16, 2025 · 38-for-1
Related
RDIMCSCNKAMC
RGC Profile

we are an early-stage bioscience company that focuses on research, development and commercialization of tcm for the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder ("adhd"), autism spectrum disorder ("asd") in infectious diseases such as covid-19. our goal is to improve the lives of adhd, asd and covid patients, their families and caregivers and become a market leader for the best tcm treatment globally.

RGC Performance
PeriodPriceDateChangeBeta
1W7.632026-10-08+41.41%-0.093
1M5.602026-09-15+92.68%1.850
3M5.132026-07-15+110.54%2.762
6M29.812026-04-15-63.80%0.796
1Y18.762025-10-15-42.48%1.373
2Y0.142024-10-15+7466.62%—
5Y0.492021-10-15+2099.80%0.173
RGC Stock Summary

Regencell Bioscience Holdings Limited (NASDAQ:RGC) stock price today is $10.79, and today's volume is 1,549,611. RGC is up 33.046% today. The 30 day average volume is 214,649. RGC market cap is $5.35B with 495.88M shares outstanding.